Literature DB >> 18514095

TH1/TH2 immune response in lung fibroblasts in interstitial lung disease.

Atsushi Sumida1, Yoshinori Hasegawa, Masakazu Okamoto, Naozumi Hashimoto, Kazuyoshi Imaizumi, Hiroshi Yatsuya, Toyoharu Yokoi, Kenzo Takagi, Kaoru Shimokata, Tsutomu Kawabe.   

Abstract

BACKGROUND: Inflammatory response in pulmonary fibrosis closely resembles a T-helper (Th) 2 immune response. For recruitment to an inflammatory lesion, the majority of Th1 cells express CXC chemokine receptor 3, recognizing monokine induced by interferon-gamma (Mig), interferon gamma-inducible protein of 10 kD (IP-10), and interferon-inducible T-cell alpha chemoattractant (I-TAC). Th2 cells express CC chemokine receptor 4, recognizing thymus- and activation-regulated chemokine (TARC) and macrophage-derived chemokine (MDC). We investigated the Th1/Th2 chemokine production patterns by lung fibroblasts and their evaluation in bronchoalveolar lavage (BAL) fluid of interstitial lung disease.
METHODS: The production pattern of Th1/Th2 chemokines by lung fibroblasts was examined in ELISA and quantitative reverse transcriptase polymerase chain reactions. Th1/Th2 chemokine levels in BAL fluid of idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP) were examined to evaluate the clinical relevance of Th1/Th2 chemokines.
RESULTS: The lung fibroblasts were polarized to produce Th1-type chemokines by the pro-inflammatory cytokine, tumor necrosis factor (TNF)-alpha and the anti-fibrotic cytokine, interferon (IFN)-gamma. However, the induction patterns of chemokines by these two cytokines were different, i.e., involving predominant induction of IP-10 and I-TAC by TNF-alpha and induction of Mig by IFN-gamma. Although Mig, IP-10, and I-TAC were produced within the BAL fluid of patients, TARC and MDC were at significantly low levels.
CONCLUSIONS: Our results suggest that lung fibroblasts tend to induce a Th1-type immune response under normal conditions, and that a Th2-type immune response does not play a significant role in smoldering inflammation around the established lesions in IPF and NSIP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18514095     DOI: 10.1016/j.arcmed.2008.02.005

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  11 in total

1.  Aryl hydrocarbon receptor (AhR) regulates silica-induced inflammation but not fibrosis.

Authors:  Celine A Beamer; Benjamin P Seaver; David M Shepherd
Journal:  Toxicol Sci       Date:  2012-01-23       Impact factor: 4.849

2.  Innate immune processes are sufficient for driving silicosis in mice.

Authors:  Celine A Beamer; Christopher T Migliaccio; Forrest Jessop; Melanie Trapkus; Dorothy Yuan; Andrij Holian
Journal:  J Leukoc Biol       Date:  2010-06-24       Impact factor: 4.962

3.  Thy-1 attenuates TNF-alpha-activated gene expression in mouse embryonic fibroblasts via Src family kinase.

Authors:  Bin Shan; James S Hagood; Ying Zhuo; Hong T Nguyen; Mark MacEwen; Gilbert F Morris; Joseph A Lasky
Journal:  PLoS One       Date:  2010-07-19       Impact factor: 3.240

4.  Clinical efficacy of Baihe Gujin decoction combined with anti-tuberculosis therapy for pulmonary tuberculosis with Yin-deficiency and Fire-hyperactivity syndrome.

Authors:  Hai-Bo Ge; Jia Zhu
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

5.  Air pollutants and development of interstitial lung disease in patients with connective tissue disease: a population-based case-control study in Taiwan.

Authors:  Jia-Ching Ying; Wen-Cheng Chao; Hsin-Hua Chen; You-Ming Yong; Ching-Heng Lin; Yi-Hsing Chen; Der-Yuan Chen
Journal:  BMJ Open       Date:  2020-12-28       Impact factor: 2.692

Review 6.  Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis.

Authors:  Hongbo Ma; Xuyi Wu; Yi Li; Yong Xia
Journal:  Front Pharmacol       Date:  2022-07-21       Impact factor: 5.988

7.  A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis.

Authors:  Yong Huang; Shwu-Fan Ma; Rekha Vij; Justin M Oldham; Jose Herazo-Maya; Steven M Broderick; Mary E Strek; Steven R White; D Kyle Hogarth; Nathan K Sandbo; Yves A Lussier; Kevin F Gibson; Naftali Kaminski; Joe G N Garcia; Imre Noth
Journal:  BMC Pulm Med       Date:  2015-11-21       Impact factor: 3.317

8.  Prognosis of nonspecific interstitial pneumonia correlates with perivascular CD4+ T lymphocyte infiltration of the lung.

Authors:  Ling Qin; WenZe Wang; HongRui Liu; Yi Xiao; MingWei Qin; WenJie Zheng; JuHong Shi
Journal:  BMC Pulm Med       Date:  2015-10-24       Impact factor: 3.317

9.  Risk Factors and Changes of Peripheral NK and T Cells in Pulmonary Interstitial Fibrosis of Patients with Rheumatoid Arthritis.

Authors:  Na-Lin Lai; Wen Jia; Xia Wang; Jing Luo; Guang-Ying Liu; Chong Gao; Xiao-Feng Li; Jian-Fang Xie
Journal:  Can Respir J       Date:  2019-12-01       Impact factor: 2.409

10.  Ligustilide modulates oxidative stress, apoptosis, and immunity to avoid pathological damages in bleomycin induced pulmonary fibrosis rats via inactivating TLR4/MyD88/NF-KB P65.

Authors:  Shu Luo; Junzuo Gong; Xiaoping Cao; Shiping Liu
Journal:  Ann Transl Med       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.